Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Basson

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009G M Hunt, J Ledwaba, A E Basson, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2014
Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitorsAdriaan E Basson, Soo-Yon Rhee, Chris M Parry, et al.
Frontiers in Pharmacology|January 23, 2023
Expanding the toolbox of metabolically stable lipid prodrug strategiesKiran S Toti, Nicole Pribut, Michael D'Erasmo, et al.
Journal of Medicinal Chemistry|August 30, 2021
ω-Functionalized Lipid Prodrugs of HIV NtRTI Tenofovir with Enhanced Pharmacokinetic PropertiesNicole Pribut, Michael D'Erasmo, Madhuri Dasari, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009G M Hunt, J Ledwaba, A E Basson, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2014
Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitorsAdriaan E Basson, Soo-Yon Rhee, Chris M Parry, et al.
Frontiers in Pharmacology|January 23, 2023
Expanding the toolbox of metabolically stable lipid prodrug strategiesKiran S Toti, Nicole Pribut, Michael D'Erasmo, et al.
Journal of Medicinal Chemistry|August 30, 2021
ω-Functionalized Lipid Prodrugs of HIV NtRTI Tenofovir with Enhanced Pharmacokinetic PropertiesNicole Pribut, Michael D'Erasmo, Madhuri Dasari, et al.
Pageof 4